On January 16, 2018 Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) reported that it will announce results for the Third Quarter ended December 31, 2017 on Thursday, January 25, 2018 after the Board Meeting (Press release, Dr Reddy’s, JAN 16, 2018, View Source [SID1234523139]). The results will be available on the Company’s website www.drreddys.com

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Summary of Events

Event Date and Time Medium

Release of financial results January 25th, after the Board Meeting Email, Media, Company website, Business wire

Earnings Call January 25th, 6:30 PM IST / 8:00 AM EST
Hosted by the Company

(Details below)

Webcast of Earnings Call January 25th, 6:30 PM IST / 8:00 AM EST through January 29th URL available on Company’s website, www.drreddys.com

Transcript of the Earnings call Will be available on the Company’s website URL available on Company’s website, www.drreddys.com

Press meet presentation Will be available on the Company’s website URL available on Company’s website, www.drreddys.com

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance. (Dial In and other details given below)

Audio Webcast

The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through January 29th, 2018. For play back dial in phone No: 022 3065 2322, and ID: 375#.